Additional Metadata
Persistent URL dx.doi.org/10.1038/s41397-019-0079-z, hdl.handle.net/1765/121192
Journal The Pharmacogenomics Journal
Rights no subscription
Citation
Verboom, MC, Kloth, J.S.L, Swen, J.J, Sleijfer, S, Reyners, AK, Steeghs, N, … Guchelaar, H.J. (2019). Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors. The Pharmacogenomics Journal, 19(5), 473–479. doi:10.1038/s41397-019-0079-z